The UK-hosted Global Vaccine Summit heralds a new era of global health collaboration as world leaders show overwhelming commitment to equitable immunisation coverage and global health security in the face of the COVID-19 pandemic.

Pledging announcements

3 June 2020

HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries

On the eve of the Global Vaccine Summit 2020, five manufacturers commit to increasing and prioritising HPV vaccine supply to Gavi-supported countries, which have among the highest cervical cancer burdens in the world.

3 June 2020

Private sector partners strengthen Gavi programmes with more than US$ 70 million in contributions

The commitments build on the potency of public private partnerships, which have contributed to Gavi’s success.

1 June 2020

Switzerland commits CHF 30 million to Gavi

Contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.

1 June 2020

Italy deepens support for Gavi with €150 million IFFIm pledge

Pledge follows €120 million in direct funding to Gavi Italy announced at last month’s Coronavirus Global Response pledging conference.

1 June 2020

Gavi receives US$ 5 million from The Rockefeller Foundation

Gavi receives US$ 5 million from the Rockefeller Foundation to support health workers facing COVID-19 pandemic 

1 June 2020

The UPS Foundation commits US$ 3 million to Gavi

UPS partnership with Gavi builds on successful efforts to expand and improve vaccine delivery in Uganda and some of the world’s most underserved communities.

1 June 2020

New donor Greece pledges €1.5 million to Gavi COVID response

New funding for Gavi to support lower-income countries’ response to the COVID-19 pandemic, including supporting health systems.

26 May 2020

New Zealand announces NZ$ 7 million pledge to Vaccine Alliance

Funding will support the response to the COVID-19 pandemic in lower-income countries as well as the vaccination of thousands of children in vulnerable Pacific nations.

12 May 2020

Canada commits CAD 600 million to Gavi

Canada’s contribution will go towards Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries in 2021-2025 strategic period.

11 May 2020

Spain pledges new support to Gavi

Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

6 May 2020

Italy pledges new support to Gavi

Funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

5 May 2020

Countries pledge new support to Gavi

The funding will help immunise 300 million children over the next five years, saving up to 8 million lives, as well as support universal access to COVID-19 vaccines.

4 May 2020

Norway increases commitment to immunisation for the most vulnerable, pledges USD 1 billion to Gavi

Funding will help Gavi protect the most vulnerable, particularly children, against a range of infectious diseases.

29 April 2020

Gavi welcomes UK funding pledge

Funding will support Gavi’s response to COVID-19 along with efforts to vaccinate 300 million children across the developing world, saving up to 8 million lives.

29 April 2020

Gavi welcomes US$ 10 million contribution from TikTok

Short video platform pledges to support Gavi’s life-saving immunisation programmes and future deployment of COVID-19 vaccines.

17 April 2020

Saudi Arabia pledges US$ 150 million to Gavi COVID response

Pledge follows G20 commitment to provide immediate resources to Gavi.

17 April 2020

Reed Hastings and Patty Quillin support Gavi with US$ 30 million donation

Cash donation supports the Alliance’s response to COVID-19 and helps protect the world against new outbreaks of other infectious diseases.

  • Thank you Norway
  • Thank you UK
  • Thank you Canada
  • Thank you Spain
  • Thank you Japan
  • Thank you Italy
  • Thank you Ireland
  • Thank you New Zealand
  • Thank you Greece
  • Thank you Switzerland
  • Thank you TikTok

 

Messages of support

 

 

Gavi champions and voices of support

  • H.E. Sahle-Work Zewde President of Ethiopia
  • H.E. Uhuru Kenyatta President of KenyaH.E. Sahle-Work Zewde President of Ethiopia
  • H.E. Nana Addo Dankwa Akufo-Addo President, Republic of Ghana
  • S.E.M. Issoufou Mahamadou Président de la République du Niger, Chef de l'Etat
  • H.E. Faustin-Archange Touadéra Président de la République centrafricaine

Global Vaccine Summit 2020

2020 marks an important milestone for Gavi to build on the historic gains made since its creation, 20 years ago. This meeting will bring together global leaders from the public and private sectors.

Read more

It follows Gavi’s second successful pledging conference in Berlin hosted in January 2015 by Chancellor Angela Markel under the auspices of Germany’s G7 Presidency, which raised US$ 7.5 billion for the 2016-2020 period.

The UK and Gavi

The UK is one of Gavi’s six original donors and one of two donor countries that support Gavi through all three funding channels (direct grants, IFFIm and AMC).

For the 2000-2020 period, the UK has committed USD 3 billion in direct funding (2000-2020), of which USD 61 million (GBP 50 million) is allocated to the Matching Fund (2011-2015). Moreover, the UK has pledged USD 2.7 billion in IFFIm (for 2007-2029), USD 485 million to the pneumococcal AMC (for 2010-2018) and USD 40 million to IPV (for 2013-2018).

In 2011, Prime Minister David Cameron hosted Gavi’s donor pledging conference in London.

The 2021-2025 Investment Opportunity

Gavi's Investment Opportunity was launched at a high-level meeting hosted by the Government of Japan on the occasion of the 7th Tokyo International Conference on African Development (TICAD) in Yokohama on 30 August 2019. Prime Minister Abe announced Gavi’s Investment Opportunity launch in his opening speech at TICAD.

Read more

The Investment Opportunity highlighted that more children have been immunised with a wider range of vaccines than at any time in history.  With support from Gavi’s partners and bold commitments from donors, implementing countries and the private sector, the Alliance is poised to bring about even greater impact in the coming five years. Through its innovative approach to development, including innovative finance, the Alliance will help countries PREVENT disease with vaccines in order to PROTECT the next generation and ensure countries can PROSPER. By working together, and with enough support, we can achieve more impact, more efficiently and at a lower cost to donors than ever before.

With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:

  • Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
  • Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
  • Contribute to a further US$ 80–100 billion in economic benefits.
  • Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets

In order to deliver on its ambitious plans and deliver the most comprehensive package of protection in Alliance history, Gavi will need at least US$ 7.4 billion in additional resources for the period 2021–2025.

With countries squarely in the driving seat, Gavi will help foster long-term sustainability and vaccine supply security through its unique transition model and market shaping efforts. Our work together – leveraging donor financing, empowering countries, shaping sustainable markets – will:

  • Allow us to achieve the Alliance’s goals and reach a further 300 million children between 2021 and 2025 and, through the full protection of the broadest vaccine portfolio in history, save an additional 7–8 million lives.
  • Catalyse country contributions of US$ 3.6 billion in domestic co-financing and self-funded vaccine programmes.
  • Contribute to a further US$ 80–100 billion in economic benefits.
  • Enhance the competitiveness and supply security of at least five Gavi-supported vaccine markets
Figure 1: Cumulative vaccination and lives saved by 2025

Pivotal moment

This ambitious programme is realistic and within reach. Without critical funding however, we run the risk of losing the momentum of our hard-fought gains and even backsliding.

The next strategic period will be a critical one for Gavi and represents a turning point in our history. With the political will and investment of countries, the ingenuity of Alliance partners, and the generosity of its donors, we can achieve a world where we can make vaccines work for all.

Figure 2: Leveraging country financing for Gavi-supported vaccines

Prevent, Protect, Prosper

This is the time to build on the unprecedented gains from Gavi’s past investments and historical achievements to bring about continued acceleration of immunisation.

Its collaborative model brings the best resources in global health and immunisation together and can continue to use innovation to achieve even stronger impact. Now is not the time for complacency. Now is the time for renewed commitment to help countries prevent disease, protect their communities and, above all, prosper.

Featured content

20 October 2021

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19, with 21 vaccines now being rolled out in countries worldwide. Here is an at-a-glance overview of those vaccines and…

2 December 2020

Five ways that scientists are ensuring the safety of COVID-19 vaccines

As companies race to develop COVID-19 vaccines, some development processes have been run in parallel to stop the pandemic as quickly as possible. Yet safety remains paramount; now that we are on the brink of rolling out some of the vaccines that…

15 October 2020

Why handwashing with soap is the most effective way to stop viruses

Global Handwashing Day and the ongoing spread of COVID-19 is a timely reminder about the importance of handwashing with soap as an effective and affordable way to stay healthy.

15 October 2020

COVID-19 as an awakening for hand hygiene access

As the pandemic unfolded around the world, hand sanitizer and handwashing stations became as in-demand as toilet paper.

9 October 2020

The World Food Programme wins 2020 Nobel Peace Prize amidst ‘hunger pandemic’ triggered by COVID-19

These global efforts are increasingly urgent as the economic impact of the COVID-19 pandemic continues to put millions of lives at risk from famine and malnutrition.

9 October 2020

Will silent reinfections drive the spread of COVID?

People who have had COVID-19 can develop an immune response that normally protects people from recurrent infection. But now that reinfections of COVID-19 have been recorded, what does that mean for our ability to fight the virus?

9 October 2020

Immunization continues amid COVID-19

European Commission Civil Protection and Humanitarian Aid Operations (ECHO) humanitarian air bridge made it possible

8 October 2020

Protecting community health workers means protecting communities in the DRC

Preventing and controlling infectious disease is possible with dedication of health workers, multi-stakeholder collaboration and equitable access to vaccines. Africa’s wild polio-free certification, which took decades of collaborative effort, is…

8 October 2020

10 things we have now learned about COVID-19

Just over six months since COVID-19 was declared a pandemic, what do we know about this new coronavirus?

7 October 2020

What are monoclonal antibodies – and can they treat Covid-19?

For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.

7 October 2020

How emergency use authorisations could accelerate access to COVID-19 vaccines

Emergency use procedures are designed to make potentially life-saving medical products available as quickly as possible during health emergencies. A record number have been granted since the arrival of COVID-19 pandemic, but what does this mean…

6 October 2020

AVADAR: How digital health fast-tracked Nigeria’s drive to eradicate polio

Polio, a contagious disease caused by the poliomyelitis virus is transmitted primarily when stool from someone infected contaminates foods, drinks or water sources. It invades the nervous system and could, in a matter of hours, lead to complete…

6 October 2020

Why I volunteered for a COVID-19 vaccine trial

Vaccines are designed to trigger an immune response to pathogens we’ve never encountered before. But how does it feel to be one of the first humans to encounter a new vaccine? British communications consultant Heather Macdonald-Tait explains what…

5 October 2020

How COVID-19 is heightening the economic risks in Gavi-supported countries

In a matter of months, the COVID-19 pandemic has devastated the global economy. Now a new study looks at how this economic shock is impacting sovereign debt levels of Gavi-supported countries.

5 October 2020

Q&A with Professor Salim Karim

Africa has not been as hard hit by the COVID-19 pandemic as predicted. Here, we talk to Professor Salim Abdool Karim, the head of South Africa's Ministerial Advisory Committee on COVID-19 to find out why and what the future might hold.

2 October 2020

Why the world is at risk without immunisation

Vaccines save lives by protecting children and adults from diseases. COVID-19 pandemic is a clear example of what a world without vaccines could look like. Governments should ensure that delivery of essential services such as vaccines remains a…

2 October 2020

How good quality data is vital to saving lives

Throughout the 2016–2020 strategic period, the Vaccine Alliance has worked with countries to improve data quality. From GIS to SMS, new tech and tools aim to reach more people with life-saving immunisation.

1 October 2020

How Gavi’s co-financing model works

To bring countries on a trajectory towards financial sustainability, and to empower them to take ownership
of their vaccination programmes, Gavi has pioneered an approach to co-financing and transition.

1 October 2020

A Nurse in Uganda is a Trusted Messenger of Hope

Her own healthy baby son is how Ugandan nurse Maureen Wandawa demonstrates the benefits of immunization. Working together to build confidence in, and access to, vaccines for all who need them is one way we can #UniteforHealth to keep us all safer…

30 September 2020

Download for life: a mobile app to improve vaccine coverage in Côte d’Ivoire

Gavi's partnership with telecoms provider Orange and the Ministry of Health overcomes barriers to childhood immunisation through tailored, tested technology.

Last updated: 13 Aug 2020

Subscribe to our newsletter